El-Naggar A - Search Results

1

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.

Reles A, Wen WH, Schmider A, Gee C, Runnebaum IB, Kilian U, Jones LA, El-Naggar A, Minguillon C, Schönborn I, Reich O, Kreienberg R, Lichtenegger W, Press MF. Reles A, et al. Clin Cancer Res. 2001 Oct;7(10):2984-97. Clin Cancer Res. 2001. PMID: 11595686

2

Transitional cell carcinoma in high-grade high-stage ovarian carcinoma. An indicator of favorable response to chemotherapy.

Robey SS, Silva EG, Gershenson DM, McLemore D, el-Naggar A, Ordonez NG. Robey SS, et al. Cancer. 1989 Mar 1;63(5):839-47. doi: 10.1002/1097-0142(19890301)63:5<839::aid-cncr2820630508>3.0.co;2-u. Cancer. 1989. PMID: 2644014

3

Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.

Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF. Saffari B, et al. Cancer Res. 1995 Dec 1;55(23):5693-8. Cancer Res. 1995. PMID: 7585656

4

Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma.

el-Naggar AK, Lai S, Luna MA, Zhou XD, Weber RS, Goepfert H, Batsakis JG. el-Naggar AK, et al. Int J Cancer. 1995 Jun 22;64(3):196-201. doi: 10.1002/ijc.2910640309. Int J Cancer. 1995. PMID: 7622308

5

Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma.

Felix A, El-Naggar AK, Press MF, Ordonez NG, Fonseca I, Tucker SL, Luna MA, Batsakis JG. Felix A, et al. Hum Pathol. 1996 Jun;27(6):561-6. doi: 10.1016/s0046-8177(96)90162-8. Hum Pathol. 1996. PMID: 8666365

6

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.

Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A, Slamon DJ, Phillips RN, Ross JS, Wolman SR, Flom KJ. Press MF, et al. J Clin Oncol. 1997 Aug;15(8):2894-904. doi: 10.1200/JCO.1997.15.8.2894. J Clin Oncol. 1997. PMID: 9256133

7

The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma.

Jin YT, Kayser S, Kemp BL, Ordonez NG, Tucker SL, Clayman GL, Goepfert H, Luna MA, Batsakis JG, El-Naggar AK. Jin YT, et al. Cancer. 1998 Jun 1;82(11):2159-65. Cancer. 1998. PMID: 9610695

8

Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA content.

El-Naggar AK, Kemp BL, Sneige N, Hurr KG, Steck K, Tu ZN, Fritsche HA, Singletary SE, Balch CM. El-Naggar AK, et al. Clin Cancer Res. 1996 Feb;2(2):419-26. Clin Cancer Res. 1996. PMID: 9816186

9

Trisomy 7 by dual-color fluorescence in situ hybridization: a potential biological marker for prostate cancer progression.

Wang RY, Troncoso P, Palmer JL, El-Naggar AK, Liang JC. Wang RY, et al. Clin Cancer Res. 1996 Sep;2(9):1553-8. Clin Cancer Res. 1996. PMID: 9816332

10

p53 mutations and expression in ovarian cancers: correlation with overall survival.

Wen WH, Reles A, Runnebaum IB, Sullivan-Halley J, Bernstein L, Jones LA, Felix JC, Kreienberg R, el-Naggar A, Press MF. Wen WH, et al. Int J Gynecol Pathol. 1999 Jan;18(1):29-41. doi: 10.1097/00004347-199901000-00005. Int J Gynecol Pathol. 1999. PMID: 9891239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,103 results

Search Page

Filters